Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.

Poly(lactic acid) [PLA] and its co-polymers with glycolic acid [PLCG] have been known to be biodegradable and histocompatible for the past 20 years. Their physico-chemical and biological properties have been found suitable, in many instances, for sustaining drug release in vivo for days or months. Several dosage forms for parenteral administration have been investigated using these polymers and a microencapsulation technique is chosen frequently for its unique properties. There are a limited number of published papers concerning preparation and characterization of PLA or PLCG microcapsules, possibly because of commercial unavailability and difficulties in the synthesis of reproducible batches of these polymers. However, microcapsules can be made using different traditional and non-traditional techniques containing core materials ranging from biological proteins to synthetic drugs. An attempt is made here to review problems associated with the different microencapsulation techniques using PLA or PLCG. In vivo and in vitro drug release from these microcapsules is also reviewed.

[1]  R. Jalil,et al.  Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics. , 1990, Journal of microencapsulation.

[2]  R. Jalil,et al.  Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics. , 1990, Journal of microencapsulation.

[3]  R. Jalil,et al.  Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties. , 1990, Journal of microencapsulation.

[4]  R. Jalil,et al.  Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties. , 1990, Journal of microencapsulation.

[5]  R. Jalil,et al.  Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone. , 1990, Journal of microencapsulation.

[6]  R. Jalil,et al.  Microencapsulation using poly(L-lactic acid). I: Microcapsule properties affected by the preparative technique. , 1989, Journal of microencapsulation.

[7]  H. Okada,et al.  Controlled Release of LHRH Agonist, Leuprolide Acetate, from Microcapsules: Serum Drug Level Profiles and Pharmacological Effects in Animals , 1989, The Journal of pharmacy and pharmacology.

[8]  R. Bodmeier,et al.  The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems , 1989 .

[9]  J. Benoit,et al.  Microencapsulation of peptide: a study of the phase separation of poly(d,l-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil , 1989 .

[10]  R. Bodmeier,et al.  Preparation of Biodegradable Poly(±)lactide Microparticles Using a Spray‐Drying Technique , 1988, The Journal of pharmacy and pharmacology.

[11]  H. Okada,et al.  In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. , 1988, Chemical & pharmaceutical bulletin.

[12]  H. Okada,et al.  Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. , 1988, Chemical & pharmaceutical bulletin.

[13]  C. Malanga,et al.  A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading. , 1988, Journal of microencapsulation.

[14]  T Yashiki,et al.  A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.

[15]  N. Leelarasamee,et al.  Effect of surface active agents on drug release from polylactic acid-hydrocortisone microcapsules. , 1988, Journal of microencapsulation.

[16]  R. Bodmeier,et al.  Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies. , 1988, Journal of microencapsulation.

[17]  T. Chang,et al.  Control release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles. , 1988, Journal of microencapsulation.

[18]  H. V. Maulding Prolonged delivery of peptides by microcapsules , 1987 .

[19]  R. Bodmeier,et al.  Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology. , 1987, Journal of microencapsulation.

[20]  R. Bodmeier,et al.  Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres. , 1987, Journal of microencapsulation.

[21]  G. E. Visscher,et al.  Enhancing Drug Release from Polylactide Microspheres by Using Base in the Microencapsulation Process , 1987 .

[22]  F. Hutchinson,et al.  Biodegradable carriers for the sustained release of polypeptides , 1987 .

[23]  J. Benoit,et al.  Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. , 1986, Journal of pharmaceutical sciences.

[24]  Alan Smith,et al.  Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration , 1986 .

[25]  G. E. Visscher,et al.  Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules. , 1986, Journal of biomedical materials research.

[26]  J. Benoit,et al.  A physicochemical study of the morphology of progesterone-loaded poly (d,l-lactide) microspheres , 1986 .

[27]  C. Thies,et al.  The formation and characterization of hydrocortisone‐loaded poly((±)‐lactide) microspheres , 1986, The Journal of pharmacy and pharmacology.

[28]  H. V. Maulding,et al.  Evaluation of biodegradable microspheres prepared by a solvent evaporation process using sodium oleate as emulsifier , 1986 .

[29]  T. Tice,et al.  Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament , 1986 .

[30]  T. Hogan,et al.  Preparation and in vitro evaluation of polylactic acid-mitomycin C microcapsules. , 1986, Journal of microencapsulation.

[31]  T. Kondo,et al.  Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration. , 1986, Journal of microencapsulation.

[32]  T. Hogan,et al.  Kinetics of drug release from polylactic acid-hydrocortisone microcapsules. , 1986, Journal of microencapsulation.

[33]  P. Rohdewald,et al.  Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs , 1985 .

[34]  T. Tice,et al.  Preparation of injectable controlled-release microcapsules by a solvent-evaporation process , 1985 .

[35]  L. M. Sanders,et al.  Controlled delivery of an LHRH analogue from biodegradable injectable microspheres , 1985 .

[36]  J. Cummings,et al.  In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres. , 1985, Journal of microencapsulation.

[37]  M. Nakano,et al.  Control of release rate of bleomycin from polylactic acid microspheres by additives. , 1985, Chemical & pharmaceutical bulletin.

[38]  C. Chu Degradation phenomena of two linear aliphatic polyester fibres used in medicine and surgery , 1985 .

[39]  T. Kondo,et al.  Preparation and in vitro degradation properties of polylactide microcapsules. , 1985, Chemical & pharmaceutical bulletin.

[40]  H. Klemcke,et al.  Prolonged suppression of plasma LH levels in male rats after a single injection of an LH-RH agonist in poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of andrology.

[41]  G E Visscher,et al.  Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of biomedical materials research.

[42]  M. Nakano,et al.  Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. , 1982, Chemical & pharmaceutical bulletin.

[43]  C. Rostron,et al.  The preparation and characterization of poly(D,L-lactic acid) for use as a biodegradable drug carrier. , 1985, Pharmaceutica acta Helvetiae.

[44]  D. Wise,et al.  Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. , 1985, Methods in enzymology.

[45]  T. Tice,et al.  Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. , 1985, Methods in enzymology.

[46]  S. Pepeljnjak,et al.  The in vivo evaluation of poly(lactic acid) microcapsules of pilocarpine hydrochloride. , 1985, Journal of microencapsulation.

[47]  J. C. Price,et al.  Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide). , 1985, Journal of pharmaceutical sciences.

[48]  J. Benoit,et al.  Characterization of drug-loaded poly(d,l-lactide) microspheres. , 1984, Journal of pharmaceutical sciences.

[49]  D. Lewis,et al.  Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres. , 1984, Journal of pharmaceutical sciences.

[50]  S. Davis,et al.  Preparation and evaluation of biodegradable polymeric systems for the intra‐articular delivery of drugs , 1984, The Journal of pharmacy and pharmacology.

[51]  P. B. Deasy,et al.  Microencapsulation and related drug processes , 1984 .

[52]  I. Jalšenjak,et al.  Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation. , 1984, Journal of microencapsulation.

[53]  T. Kondo,et al.  A new method of preparing monocored water-loaded microcapsules using interfacial polymer deposition process. , 1984, Journal of microencapsulation.

[54]  L. R. Beck,et al.  Clinical evaluation of an improved injectable microcapsule contraceptive system. , 1983, American journal of obstetrics and gynecology.

[55]  M. Goosen,et al.  Long-acting Insulin: Slow Release of Insulin from a Biodegradable Matrix Implanted in Diabetic Rats , 1983, Diabetes.

[56]  D. Lewis,et al.  Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. , 1983, Biology of reproduction.

[57]  M. Nakano,et al.  Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics. , 1982, Chemical & pharmaceutical bulletin.

[58]  B. Sears,et al.  Experimental methods in cancer therapeutics. , 1982, Journal of pharmaceutical sciences.

[59]  M. Nakano,et al.  Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. , 1981, Chemical & pharmaceutical bulletin.

[60]  J. Anderson,et al.  The role of the fibrous capsule in the function of implanted drug-polymer sustained release systems. , 1981, Journal of biomedical materials research.

[61]  D. Lewis,et al.  Clinical evaluation of injectable biodegradable contraceptive system. , 1981, American journal of obstetrics and gynecology.

[62]  K. Sugibayashi,et al.  Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats. , 1981, Chemical & pharmaceutical bulletin.

[63]  Yoshioka Toshio,et al.  Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and m1crospherical carriers of gelatin , 1981 .

[64]  N. Peppas,et al.  Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs , 1981 .

[65]  K. Widder,et al.  In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. , 1980, Cancer research.

[66]  D. Wise,et al.  Long‐term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders , 1980, The Journal of pharmacy and pharmacology.

[67]  Nakano Masahiro,et al.  Sustained urinary excretion of sulfamethizole following oral administration of enteric coated microcapsules in humans , 1980 .

[68]  Ross R. Muth,et al.  Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .

[69]  A. Schindler,et al.  Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. , 1979, Journal of pharmaceutical sciences.

[70]  J. W. Gibson,et al.  New long-acting injectable microcapsule contraceptive system. , 1979, American journal of obstetrics and gynecology.

[71]  H. Gabelnick,et al.  Biodegradable systems for the sustained release of fertility-regulating agents. , 1979, Journal of steroid biochemistry.

[72]  A. Schindler,et al.  Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers , 1979 .

[73]  T. Epperly,et al.  A new long-acting injectable microcapsule system for the administration of progesterone. , 1979, Fertility and sterility.

[74]  K. Widder,et al.  Magnetic microspheres: synthesis of a novel parenteral drug carrier. , 1979, Journal of pharmaceutical sciences.

[75]  D. Wise,et al.  Sustained release of sulphadiazine , 1978, The Journal of pharmacy and pharmacology.

[76]  J M Brady,et al.  Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. , 1977, Journal of biomedical materials research.

[77]  G. Wilkes,et al.  Some mechanical property considerations of reconstituted collagen for drug release supports. , 1977, Biomaterials, medical devices, and artificial organs.

[78]  F. Boettner,et al.  Controlled release of biologically active drugs. , 1976, Bulletin of the Parenteral Drug Association.

[79]  D. Wise,et al.  Sustained release of an antimalarial drug using a copolymer of glycolic/lactic acid. , 1976, Life sciences.

[80]  C. Thies Characterization of Microcapsules Containing Naltrexone or Naltrexone Pamoate , 1976 .

[81]  T. Cicero,et al.  In vivo and in vitro evaluation of a microencapsulated narcotic antagonist. , 1976, Journal of pharmaceutical sciences.

[82]  S. Yolles,et al.  Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites. , 1975, Journal of pharmaceutical sciences.

[83]  S. Yolles,et al.  Timed-release depot for anticancer agents. , 1975, Journal of pharmaceutical sciences.

[84]  R. A. Miller,et al.  Single dose, long duration, subcutaneous drug administration. , 1975, Journal of oral medicine.

[85]  W. Wardell Clinical Pharmacology at University Medical Centers. I. Functions and Organization , 1974, Journal of clinical pharmacology.

[86]  W. J. Larson,et al.  Degradation rates of polymers and copolymers of polylactic and polyglycolic acids. , 1974, Oral surgery, oral medicine, and oral pathology.

[87]  D. Wise,et al.  POLYLACTIC ACID AS A BIODEGRADABLE CARRIER FOR CONTRACEPTIVE STEROIDS , 1973 .

[88]  T. Miyata,et al.  Collagen as a Vehicle for Drug Delivery , 1973 .

[89]  J M Brady,et al.  Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. , 1973, Journal of biomedical materials research.

[90]  D. E. Cutright,et al.  Histologic comparison of polylactic and polyglycolic acid sutures. , 1971, Oral surgery, oral medicine, and oral pathology.

[91]  S. D. Bruck Sterilization problems of synthetic biocompatible materials. , 1971, Journal of biomedical materials research.

[92]  F Leonard,et al.  Biodegradable poly(lactic acid) polymers. , 1971, Journal of biomedical materials research.

[93]  H. Tatum Fertility control and acceptability in women of contraceptive steroids released in microquantities from subcutaneous silastic capsules , 1970 .

[94]  H. Wagner,et al.  Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. , 1970, The International journal of applied radiation and isotopes.

[95]  K C Pani,et al.  Polylactic acid for surgical implants , 1966, Archives of surgery.

[96]  W I Higuchi,et al.  Investigation of factors influencing release of solid drug dispersed in inert matrices. , 1966, Journal of pharmaceutical sciences.

[97]  J. Folkman,et al.  THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY. , 1964, The Journal of surgical research.

[98]  T. Higuchi MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[99]  T. Higuchi,et al.  Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.